Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$0.65 - $1.02 $195,035 - $306,056
-300,055 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$1.01 - $1.25 $101,000 - $125,000
100,000 Added 49.99%
300,055 $315,000
Q2 2021

Aug 24, 2021

BUY
$1.08 - $2.14 $216,059 - $428,117
200,055 New
200,055 $250,000

About Cocrystal Pharma, Inc.


  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $14.3M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.